CRGX Valuation

CARGO Therapeutics Inc

Add to Watchlist

Advanced Chart

4.520

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

CRGX Relative Valuation

CRGX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CRGX is overvalued; if below, it's undervalued.

Historical Valuation

CARGO Therapeutics Inc (CRGX) is now in the Fair zone, suggesting that its current forward PS ratio of 124.10 is considered Fairly compared with the five-year average of -3.52. The fair price of CARGO Therapeutics Inc (CRGX) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：4.52

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.74

P/B

Median3y

1.45

Median5y

1.45

-71.74

FCF Yield

Median3y

-31.77

Median5y

-31.77

Competitors Valuation Multiple

The average P/S ratio for CRGX's competitors is 24.96, providing a benchmark for relative valuation. CARGO Therapeutics Inc Corp (CRGX) exhibits a P/S ratio of 125.21, which is 401.72% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

CRGX.O

CARGO Therapeutics Inc

125.21

Average P/S: 24.96

210.26M